Literature DB >> 16923962

Hormonal control of androgen receptor function through SIRT1.

Maofu Fu1, Manran Liu, Anthony A Sauve, Xuanmao Jiao, Xueping Zhang, Xiaofang Wu, Michael J Powell, Tianle Yang, Wei Gu, Maria Laura Avantaggiati, Nagarajan Pattabiraman, Timothy G Pestell, Fang Wang, Andrew A Quong, Chenguang Wang, Richard G Pestell.   

Abstract

The NAD-dependent histone deacetylase Sir2 plays a key role in connecting cellular metabolism with gene silencing and aging. The androgen receptor (AR) is a ligand-regulated modular nuclear receptor governing prostate cancer cellular proliferation, differentiation, and apoptosis in response to androgens, including dihydrotestosterone (DHT). Here, SIRT1 antagonists induce endogenous AR expression and enhance DHT-mediated AR expression. SIRT1 binds and deacetylates the AR at a conserved lysine motif. Human SIRT1 (hSIRT1) repression of DHT-induced AR signaling requires the NAD-dependent catalytic function of hSIRT1 and the AR lysine residues deacetylated by SIRT1. SIRT1 inhibited coactivator-induced interactions between the AR amino and carboxyl termini. DHT-induced prostate cancer cellular contact-independent growth is also blocked by SIRT1, providing a direct functional link between the AR, which is a critical determinant of progression of human prostate cancer, and the sirtuins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923962      PMCID: PMC1636736          DOI: 10.1128/MCB.00289-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  SIRT1 and endocrine signaling.

Authors:  Tianle Yang; Maofu Fu; Richard Pestell; Anthony A Sauve
Journal:  Trends Endocrinol Metab       Date:  2006-05-08       Impact factor: 12.015

3.  Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

Authors:  S Grinspoon; C Corcoran; K Lee; B Burrows; J Hubbard; L Katznelson; M Walsh; A Guccione; J Cannan; H Heller; N Basgoz; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

4.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

5.  The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1.

Authors:  C L Bevan; S Hoare; F Claessens; D M Heery; M G Parker
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

7.  A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans.

Authors:  Y Shi; C Mello
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

8.  Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

Authors:  T Ikonen; J J Palvimo; O A Jänne
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

9.  Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.

Authors:  Alejandro Vaquero; Michael Scher; Donghoon Lee; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2004-10-08       Impact factor: 17.970

Review 10.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  115 in total

1.  SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA.

Authors:  Heather L Montie; Richard G Pestell; Diane E Merry
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

Review 2.  Circadian rhythms and cancer.

Authors:  Sigal Gery; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

3.  Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Mol Cell Endocrinol       Date:  2010-12-10       Impact factor: 4.102

4.  Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.

Authors:  Dharminder Chauhan; Madhavi Bandi; Ajita V Singh; Arghya Ray; Noopur Raje; Paul Richardson; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2011-09-26       Impact factor: 6.998

5.  A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex.

Authors:  Sean M Armour; Eric J Bennett; Craig R Braun; Xiao-Yong Zhang; Steven B McMahon; Steven P Gygi; J Wade Harper; David A Sinclair
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

6.  Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system.

Authors:  Yue Zhao; Ken-ichi Takeyama; Shun Sawatsubashi; Saya Ito; Eriko Suzuki; Kaoru Yamagata; Masahiko Tanabe; Shuhei Kimura; Sally Fujiyama; Takashi Ueda; Takuya Murata; Hiroyuki Matsukawa; Yuko Shirode; Alexander P Kouzmenko; Feng Li; Testuya Tabata; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

7.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

8.  The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.

Authors:  Ke Chen; Kongming Wu; Xuanmao Jiao; Liping Wang; Xiaoming Ju; Min Wang; Gabriele Di Sante; Shaohua Xu; Qiong Wang; Kevin Li; Xin Sun; Congwen Xu; Zhiping Li; Mathew C Casimiro; Adam Ertel; Sankar Addya; Peter A McCue; Michael P Lisanti; Chenguang Wang; Richard J Davis; Graeme Mardon; Richard G Pestell
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

Review 9.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 10.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.